Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03463915 · ClinicalTrials.gov registry record · Phase 3
Clinical Trial Comparing Two Bladder Instillations for IC/BPS
A Phase 3 study of Interstitial Cystitis and Bladder Pain Syndrome, sponsored by Olivia Cardenas-Trowers, M.D..
- Completed
- Registry status
- Phase 3
- Development phase
- 90
- Enrollment target
- 1
- Study location
NCT03463915: Completed Phase 3 study of Interstitial Cystitis and Bladder Pain Syndrome, sponsored by Olivia Cardenas-Trowers, M.D..
NCT03463915 is a Phase 3 study of Interstitial Cystitis and Bladder Pain Syndrome that has completed, run by Olivia Cardenas-Trowers, M.D.. The registered enrollment target is 90 participants, below the 359-participant average among 26 other Interstitial Cystitis trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03463915, a Phase 3 study of Interstitial Cystitis and Bladder Pain Syndrome, has completed, sponsored by Olivia Cardenas-Trowers, M.D..
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 90 participants
- Enrollment target
- 1
- Study location
Study Summary
Interstitial cystitis/bladder pain syndrome (IC/BPS) is a condition that results in long-term bladder and pelvic pain. IC/BPS affects women more often than men. How the disorder develops is not completely known. Bladder instillation is a commonly used treatment in which a mixture of different ingredients are passed into the bladder to help IC/BPS symptoms. There is room to learn more about bladder instillations and which ingredients in them work best. The purpose of this study is to compare the effectiveness of a bladder instillation that contains a steroid (triamcinolone acetonide) to a bladder instillation that does not contain a steroid to treat IC/BPS in women. The study hypothesis is that women with IC/BPS treated with bladder instillations that contain a steroid will have improved outcomes compared to women treated with bladder instillations that do not contain a steroid.
Primary Outcome
Total scores range: 0-36 (0= no symptoms to 36= the most severe symptoms)
Conditions Studied
Interventions
- DRUG Bladder instillation WITH triamcinolone acetonide
- DRUG Bladder instillation WITHOUT triamcinolone acetonide
Study Locations (1)
Kentucky
- University of Louisville Urogynecology at Springs Medical Center - Louisville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2019-01-25 |
| Est. Completion | 2020-10-23 |
| Phase | Phase 3 |
What the finished NCT03463915 record still lists
NCT03463915 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 359-participant average among 26 other Interstitial Cystitis trials with a reported enrollment target (75% lower).
The record links to 2 conditions, with Interstitial Cystitis appearing as the primary indexed condition, and to 2 interventions - of which Bladder instillation WITH triamcinolone acetonide is the first listed.
NCT03463915 reports a single indexed study location in Kentucky.
Frequently Asked Questions
What is clinical trial NCT03463915 about?
NCT03463915 is a clinical study titled "Clinical Trial Comparing Two Bladder Instillations for IC/BPS". Interstitial cystitis/bladder pain syndrome (IC/BPS) is a condition that results in long-term bladder and pelvic pain. IC/BPS affects women more often than men. How the disorder develops is not completely known. Bladder instillation is a commonly used treatment in which a mixture of different ingred...
What is the current status of trial NCT03463915?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 90 participants. The study started on 2019-01-25. Estimated completion is 2020-10-23.
What conditions does trial NCT03463915 study?
This clinical trial studies the following conditions: Interstitial Cystitis, Bladder Pain Syndrome.
What interventions are being tested in trial NCT03463915?
The interventions under investigation include: Bladder instillation WITH triamcinolone acetonide (DRUG), Bladder instillation WITHOUT triamcinolone acetonide (DRUG).
Who is sponsoring clinical trial NCT03463915?
This trial is sponsored by Olivia Cardenas-Trowers, M.D., which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03463915 being conducted?
This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Interstitial Cystitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03463915's enrollment target sits among peer trials
90 14th of 26 higher than 12 of 26 other Interstitial Cystitis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Interstitial Cystitis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Multidisciplinary, Multimodal Bundled Care Approach to Chronic Pelvic Pain
ACTIVE NOT RECRUITING · Phase 3
-
Efficacy of Amitriptyline for Painful Bladder Syndrome (PBS)
COMPLETED · Phase 3
-
Pain Type and Interstitial Cystitis/Bladder Pain Syndrome Treatment
RECRUITING · NA
-
Peppermint Oil for the Treatment of Interstitial Cystitis / Bladder Pain Syndrome
RECRUITING · Phase 1
-
Motor Cortical Neuromodulation in Women With Interstitial Cystitis/Bladder Pain Syndrome
RECRUITING · NA
-
Identifying Genetic Causes of IC/BPS
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI